The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $36.18 in the prior trading day, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $20.94, down -42.12%. In other words, the price has decreased by -$42.12 from its previous closing price. On the day, 43.11 million shares were traded.
Ratios:
Our goal is to gain a better understanding of SRPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.46 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.18.
H.C. Wainwright Downgraded its Neutral to Sell on June 16, 2025, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Nicaise Claude sold 2,491 shares for $99.64 per share. The transaction valued at 248,203 led to the insider holds 27,812 shares of the business.
Nicaise Claude bought 2,491 shares of SRPT for $248,226 on Mar 12 ’25. On Dec 12 ’24, another insider, Wigzell Hans Lennart Rudolf, who serves as the Director of the company, sold 10,500 shares for $124.84 each. As a result, the insider received 1,310,820 and left with 22,840 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92 while its Price-to-Book (P/B) ratio in mrq is 1.80.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $34.10. The 50-Day Moving Average of the stock is -54.34%, while the 200-Day Moving Average is calculated to be -78.62%.
Shares Statistics:
A total of 98.25M shares are outstanding, with a floating share count of 93.37M. Insiders hold about 4.99% of the company’s shares, while institutions hold 90.14% stake in the company.
